GGHC
MDXG icon

Gilder Gagnon Howe & Co’s MiMedx Group MDXG Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-776,884
Closed -$5.48M – 252
2013
Q2 		$5.48M Buy
+776,884
New +$5.43M 0.1% 138

Other funds holding MDXG

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Gilder Gagnon Howe & Co's MDXG Position: Q3 2013 in Review

Gilder Gagnon Howe & Co sold out of MiMedx Group (MDXG) in Q3 2013, closing a stake of 776,884 shares — an estimated $5.48M sold.

Gilder Gagnon Howe & Co first reported a position in MDXG in Q2 2013 and held it in 1 quarter. The position peaked at $5.48M in Q2 2013. 82 funds tracked by Wall St. Rank hold MDXG as of Q3 2013.

  • Gilder Gagnon Howe & Co reported no remaining MiMedx Group position as of Q3 2013 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 776,884 MiMedx Group shares in Q3 2013, an estimated $5.48M.
  • Gilder Gagnon Howe & Co first reported a position in MiMedx Group in Q2 2013 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's MiMedx Group position peaked at $5.48M in Q2 2013.
  • 82 funds tracked by Wall St. Rank held MiMedx Group as of Q3 2013.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2013, filed 12 Nov 2013.